Founders Simon Bolz and Dr. Simon Lorenz launched Klara in early 2014 as a B2C telemedicine app and have since then successfully evolved the product into a B2B2C messaging platform. Its cloud-based web and mobile apps are used by hundreds of health systems across the US ranging from solo-provider practices, to modern pharmacy companies, large medical groups and enterprise-level hospitals. These teams communicate with tens of thousands of patients sending hundreds of thousands of messages every month.
Simon Bolz, Co-founder and CEO of Klara said: “We see healthcare as a network, with doctors and patients being the most important nodes communicating with each other. If we want to digitize healthcare, we have to build something that both, medical staff and patients love using everyday to communicate. Providers and their staff are losing multiple hours per day being caught up in endless phone tag. Patients are frustrated by long hold times. Email as an alternative is not secure and fax is outdated. Messaging has turned out to be the perfect fabric to build this network, as it has already become the standard way to communicate in our personal and professional lives. We’re very happy that we have the ideal investors on board to follow this vision.”
“Klara fundamentally improved workflows in our practice, centralizing all patient related communication into one place. We talk to patients about appointments, results, pre- and post-visit instructions, medication, billing and much more. We also talk with colleagues about referral patients, with labs about test results and biopsy reports, and with pharmacists about medication questions, prior-authorizations and prescriptions. Klara has made everything super efficient, nothing falls between the cracks and patients are truly appreciating this new kind of access to my practice team,” says Dr. Maryann Mikhail, a dermatologist who uses Klara for almost all her patients in her 30 staff Manhattan practice.